Literature DB >> 5436699

Chromosomal abnormalities in ataxia-telangiectasia (Louis Bar's syndrome).

R A Pfeiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5436699     DOI： 10.1007/bf00280328

Source DB:  PubMed          Journal:  Humangenetik        ISSN： 0018-7348


× No keyword cloud information.
  12 in total

1.  [ATAXIA-TELANGIECTASIS].

Authors:  M LAMY; M L JAMMET; E MARTIN; B DEJOULX
Journal:  Arch Fr Pediatr       Date:  1964 Jun-Jul

2.  [CHROMOSOMAL ANALYSIS OF CANCER CELLS AND OF MEDULLARY AND BLOOD CELLS IRRADIATED "IN VITRO"].

Authors:  J DE GROUCHY; G VALLEE; C NAVA; M LAMY
Journal:  Ann Genet       Date:  1963

3.  ATAXIA TELANGIECTASIA.

Authors:  H L UTIAN; M PLIT
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-02       Impact factor: 10.154

4.  ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY.

Authors:  R D PETERSON; W D KELLY; R A GOOD
Journal:  Lancet       Date:  1964-05-30       Impact factor: 79.321

5.  IMMUNOLOGIC INCOMPETENCE IN ATAXIA-TELANGIECTASIA.

Authors:  I M ROSENTHAL; A S MARKOWITZ; R MEDENIS
Journal:  Am J Dis Child       Date:  1965-07

6.  [GENETICS OF ATAXIA-TELANGIECTASIA].

Authors:  V FERAK; J BENKO; E CAJKOVA
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1965-01

7.  [Ataxia-telangiectasia with acute lymphoblastic leukemia].

Authors:  N Taleb; S Tohmé; S Ghostine; B Barmada; S Nahas
Journal:  Presse Med       Date:  1969-02-22       Impact factor: 1.228

8.  [Acute lymphoblastic leukemia in sibblings with progressive cerebellar ataxia (Louis-Bar syndrome)].

Authors:  F Lampert
Journal:  Dtsch Med Wochenschr       Date:  1969-01-31       Impact factor: 0.628

9.  Chromosome breakage and blastic transformation of lymphocytes in ataxia-telangiectasia.

Authors:  A Gropp; G Flatz
Journal:  Humangenetik       Date:  1967-11-29

10.  In vitro lymphocyte transformation in ataxia telangiectasia.

Authors:  S L Leikin; M Bazelon; K H Park
Journal:  J Pediatr       Date:  1966-03       Impact factor: 4.406
View more
  13 in total

Review 1.  Genetic and biochemical studies with ataxia telangiectasia. A review.

Authors:  P C Huang; R B Sheridan
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

2.  Specific chromosome aberrations in ataxia telangiectasia.

Authors:  J M Oxford; D G Harnden; J M Parrington; J D Delhanty
Journal:  J Med Genet       Date:  1975-09       Impact factor: 6.318

3.  Variant of ataxia-telangiectasia with low-level radiosensitivity.

Authors:  M Fiorilli; A Antonelli; G Russo; M Crescenzi; M Carbonari; P Petrinelli
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  In vitro lymphocytic transformation chromosome breakage and cellular damage in Ataxia-Telangiectasia.

Authors:  Y Ros
Journal:  Humangenetik       Date:  1975

5.  Tissue specificity of chromosomal rearrangements in ataxia-telangiectasia.

Authors:  T L Kojis; R R Schreck; R A Gatti; R S Sparkes
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

6.  In vivo chromosomal instability in ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  M P Rosin; H D Ochs
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

7.  Cytogenetic study of patients with ataxia-telangiectasia.

Authors:  N P Bochkov; Y M Lopukhin; N P Kuleshov; L V Kovalchuk
Journal:  Humangenetik       Date:  1974

8.  Evolution of chromosomal abnormalities in sequential cytogenetic studies of ataxia telangiectasia.

Authors:  A Al Saadi; M Palutke; G K Kumar
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

9.  Cytogenetic studies in an acute leukemia patient following cerebellar astrocytoma.

Authors:  A Nora; R Heideman; D Peakman; H Morse
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

10.  Heterogeneity of chromosomal breakage levels in epithelial tissue of ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  M P Rosin; H D Ochs; R A Gatti; E Boder
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.